ArticleEmerging microbes & infections2021

One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization.

Maggie Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.